Metastatic Renal Cell Carcinoma With Partial Response to Sunitinib Complicated by Ureteral Obstruction From Necrotic Tumor

Urology

Volumn 73, Issue 2, 2009, Pages 444.e11-444.e12

  Meeks, Joshua J ^a   Kasper, Kathrine A ^a   Yang, Ximing ^a   Kuzel, Timothy M ^a   Smith, Norm D ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; SUNITINIB;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; BRAIN METASTASIS; CASE REPORT; CLEAR CELL CARCINOMA; DRUG RESPONSE; FEMALE; FLANK PAIN; GAMMA KNIFE RADIOSURGERY; HUMAN; HYDRONEPHROSIS; KIDNEY CARCINOMA; KIDNEY METASTASIS; KIDNEY NECROSIS; LIVER METASTASIS; MULTIPLE CYCLE TREATMENT; NECROTIC RENAL CELL CARCINOMA; NEPHRECTOMY; PRIORITY JOURNAL; RADIOGRAPHY; SOLITARY KIDNEY; TUBE; TUMOR BIOPSY; URETER OBSTRUCTION; URETEROSCOPY;

EID: 58649094882     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2008.02.016     Document Type: Article

References (5)

1. Motzer R.J., Hutson T.E., Tomczak P., et al. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med 356 (2007) 115-124
2. Izzedine H., Billemont B., Thibault F., et al. New challenges in kidney cancer therapy: sunitinib. Ann Oncol 18 suppl 9 (2007) ix83-ix86
3. Oudard S., George D., Medioni J., et al. Treatment options in renal cell carcinoma: past, present and future. Ann Oncol 18 (2007) x25-x31
4. Nicholaou T., Wong R., and Davis I.D. Tumour lysis syndrome in a patient with renal-cell carcinoma treated with sunitinib malate. Lancet 369 (2007) 1923-1924
5. Baccala Jr. A., Hedgepeth R., Kaouk J., et al. Pathological evidence of necrosis in recurrent renal mass following treatment with sunitinib. Int J Urol 14 (2007) 1095-1097